Home › Treatments › Oncology › Poteligeo

Poteligeo

Oncology

Manufacturer: Kyorin Pharmaceuticals Co
Salt Composition: mogamulizumab
Pack Size: One vial of 20 mg/5 mL (4 mg/mL)
Prescription Required

Introduction

Poteligeo (mogamulizumab) is a medication used to treat adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.

Safety Advice

Pregnancy: Consult Doctor

Lungs: Consult Doctor

Breastfeeding: Consult Doctor

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.